Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Ats Decline Deepens Next Support In Sight 20260403 1 What Scenarios Affect Northeast Bank Nbn Stock Price Price At 123.10 Down 0.65 20260328 Stkl Q4 2025 Earnings Sunopta Inc. 0.06 Eps Crushes 0.0269 Analyst Estimates 20260401 Cb Stock Analysis Chubb Limited Gains 0.38 Percent Daily Near 327 Dollar Level 20260401 1 What Events Could Move Pure Cycle Pcyo Stock Next Price At 10.42 Up 1.07 20260402 Biviw Stock Analysis Biovie Inc. Biotech Warrant Flat At 0.33 Full Performance Review 20260403 1 Is 1stdibs DIBS stock forming a trend channel Q4 2025 Profit Surprises Xtant XTNT Stock Social Trade Bearish Sentiment 20260418 News Corporation NWS Stock Unusual Volume Bullish Momentum 20260416 Las Vegas LVS Quarter Start Las Vegas Sands Corp Tops EPS Estimates On Strong Gaming Demand When to Sell Sixth TSLX Stock Flat 20260416 Kiniksa KNSA Stock Why It Could Continue Drifts Lower 20260415 MRTN Marten Transport Ltd Q4 2025 EPS beats consensus by 337 percent shares climb nearly 4 percent today Chart Industries GTLS Stock Red Flags Slight Downtick 20260415 GCL Global GCL Industry Ranking GCL Global Holdings posts 142M revenue 005 EPS Is J P Morgan JPML stock a good buy now JPML Earnings J P Morgan Series LL preferred posts no quarterly EPS or revenue results Textron Inc TXT PreEarnings Analysis Elevated Odds of Q1 2026 EPS Beat Amid Bullish Analyst Revisions JD JDcom posts 13 percent Q4 2025 revenue growth despite steep EPS miss shares edge higher Pacific PCG Stock Price Structure Insight Eye on Rally 20260423 EOG Resources Inc EOG Bullish Earnings Beat Prospects Ahead of Q1 2026 Results Market Moves Tech leads sector gains as consumer lags modestly Ballys BALY Stock ExDividend Play 497 20260420 Omnicom Group OMC Stock Technical Momentum Review Omnicom Group posts 18 EPS miss no revenue consensus IMCR Immunocore shares rise 156 percent on 289 percent Q4 2025 revenue growth despite wider than expected loss CRMT CarMart Q1 2026 earnings miss estimates sharply even as shares log mild gains on steady revenue What is affecting Magnachip MX stock valuation Q4 2025 Better Than Expected Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market Is Twin Vee VEEE stock under pressure Momentum Building 20260420